Grifols to acquire 45% stake in Alkahest - MarketLine Financial Deals

Grifols to acquire 45% stake in Alkahest

Grifols to acquire 45% stake in Alkahest - MarketLine Financial Deals
Grifols to acquire 45% stake in Alkahest
Published Mar 04, 2015
2 pages — Published Mar 04, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Grifols, S.A., a Spain-based healthcare company engaged in the development of blood plasma-based medicines and hospital pharmacy products, has agreed to acquire a 45% stake in Alkahest, a US-based biopharmaceutical company.

  
Source:
Document ID
MA154215_150309
Country
Country
Ticker
GRF=ES
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Grifols to acquire 45% stake in Alkahest" Mar 04, 2015. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Grifols-to-acquire-45-stake-in-Alkahest-2052-109609>
  
APA:
MarketLine Financial Deals. (2015). Grifols to acquire 45% stake in Alkahest Mar 04, 2015. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Grifols-to-acquire-45-stake-in-Alkahest-2052-109609>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.